158 related articles for article (PubMed ID: 36029153)
1. Adherence to Guideline-Recommended cancer screening among Utah cancer survivors.
Millar MM; Edwards SL; Herget KA; Orleans B; Ofori-Atta BS; Kirchhoff AC; Carter ME; Nagata M; Sweeney C
Cancer Med; 2023 Feb; 12(3):3543-3554. PubMed ID: 36029153
[TBL] [Abstract][Full Text] [Related]
2. A Workplace-Based Intervention to Improve Awareness, Knowledge, and Utilization of Breast, Cervical, and Colorectal Cancer Screenings Among Latino Service and Manual Labor Employees in Utah.
Warner EL; Martel L; Ou JY; Nam GE; Carbajal-Salisbury S; Fuentes V; Kirchhoff AC; Kepka D
J Community Health; 2019 Apr; 44(2):256-264. PubMed ID: 30306449
[TBL] [Abstract][Full Text] [Related]
3. Rural vs urban residence affects risk-appropriate colorectal cancer screening.
Anderson AE; Henry KA; Samadder NJ; Merrill RM; Kinney AY
Clin Gastroenterol Hepatol; 2013 May; 11(5):526-33. PubMed ID: 23220166
[TBL] [Abstract][Full Text] [Related]
4. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
Charkhchi P; Schabath MB; Carlos RC
J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
[No Abstract] [Full Text] [Related]
5. Colorectal cancer screening utilization among breast, cervical, prostate, skin, and lung cancer survivors.
Tsai MH; Moore JX; Odhiambo LA; Andrzejak SE; Tingen MS
J Cancer Surviv; 2024 Apr; 18(2):541-552. PubMed ID: 36217067
[TBL] [Abstract][Full Text] [Related]
6. County-Level Social Vulnerability and Breast, Cervical, and Colorectal Cancer Screening Rates in the US, 2018.
Bauer C; Zhang K; Xiao Q; Lu J; Hong YR; Suk R
JAMA Netw Open; 2022 Sep; 5(9):e2233429. PubMed ID: 36166230
[TBL] [Abstract][Full Text] [Related]
7. Modifiers of Cancer Screening Prevention Among Sexual and Gender Minorities in the Behavioral Risk Factor Surveillance System.
Charkhchi P; Schabath MB; Carlos RC
J Am Coll Radiol; 2019 Apr; 16(4 Pt B):607-620. PubMed ID: 30947895
[TBL] [Abstract][Full Text] [Related]
8. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
[TBL] [Abstract][Full Text] [Related]
9. Disparities in colorectal cancer screening among breast and prostate cancer survivors.
Dash C; Lu J; Parikh V; Wathen S; Shah S; Shah Chaudhari R; Adams-Campbell L
Cancer Med; 2021 Feb; 10(4):1448-1456. PubMed ID: 33544443
[TBL] [Abstract][Full Text] [Related]
10. Factors Influencing Adherence to Recommended Colorectal Cancer Surveillance: Experiences and Behaviors of Colorectal Cancer Survivors.
Ford ME; Sterba KR; Armeson K; Malek AM; Knight KD; Zapka J
J Cancer Educ; 2019 Oct; 34(5):938-949. PubMed ID: 30073494
[TBL] [Abstract][Full Text] [Related]
11. Cancer surveillance and preventive services in a diverse sample of breast and colorectal cancer survivors.
Glenn BA; Nonzee NJ; Hamilton AS; Tieu L; Maxwell AE; Crespi CM; Chang LC; Deapen D; Bastani R
J Cancer Surviv; 2021 Apr; 15(2):213-223. PubMed ID: 32794009
[TBL] [Abstract][Full Text] [Related]
12. Preventative Cancer Screening Rates Among Uninsured Patients in Free Clinics: A Retrospective Cohort Study of Cancer Survivors and Non-cancer Survivors.
MacDonald M; Mirza AS; Mhaskar R; Ewing A; Chen L; Robinson K; Lu Y; Ayoubi N; Gonzalez E; Guerra L; Roetzheim R; Woodard L; Pabbathi S
Cancer Control; 2022; 29():10732748211072983. PubMed ID: 35245986
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk perception and physician communication behaviors on cervical cancer and colorectal cancer screening.
Harper DM; Tariq M; Alhawli A; Syed N; Patel M; Resnicow K
Elife; 2021 Aug; 10():. PubMed ID: 34427182
[TBL] [Abstract][Full Text] [Related]
14. Assessment of US Preventive Services Task Force Guideline-Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019.
Suk R; Hong YR; Rajan SS; Xie Z; Zhu Y; Spencer JC
JAMA Netw Open; 2022 Jan; 5(1):e2143582. PubMed ID: 35040970
[TBL] [Abstract][Full Text] [Related]
15. Cancer Screening Test Use-U.S., 2019.
Sabatino SA; Thompson TD; White MC; Shapiro JA; Clarke TC; Croswell JM; Richardson LC
Am J Prev Med; 2022 Sep; 63(3):431-439. PubMed ID: 35469700
[TBL] [Abstract][Full Text] [Related]
16. Cancer survivorship experiences in Utah: an evaluation assessing indicators of survivors' quality of life, health behaviors, and access to health services.
Millar MM; Herget KA; Ofori-Atta B; Codden RR; Edwards SL; Carter ME; Belnap B; Kirchhoff AC; Sweeney C
Cancer Causes Control; 2023 Apr; 34(4):337-347. PubMed ID: 36723708
[TBL] [Abstract][Full Text] [Related]
17. Adherence to Guideline-Recommended Cancer Screening in Stroke Survivors: A Nationwide Analysis.
Simonetto M; Rutrick S; LeMoss NM; Lansdale KN; Tagawa ST; Kamel H; Parikh N; Navi BB
J Stroke Cerebrovasc Dis; 2022 Mar; 31(3):106297. PubMed ID: 35032754
[TBL] [Abstract][Full Text] [Related]
18. US women screen at low rates for both cervical and colorectal cancers than a single cancer: a cross-sectional population-based observational study.
Harper DM; Plegue M; Jimbo M; Sheinfeld Gorin S; Sen A
Elife; 2022 Jun; 11():. PubMed ID: 35762572
[TBL] [Abstract][Full Text] [Related]
19. Determinants of breast, cervical and colorectal cancer screening adherence in Mexican-American women.
Gonzalez P; Castaneda SF; Mills PJ; Talavera GA; Elder JP; Gallo LC
J Community Health; 2012 Apr; 37(2):421-33. PubMed ID: 21874364
[TBL] [Abstract][Full Text] [Related]
20. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
